Safety Lancets Market

Lancets are a pricking needle used to obtain drops of blood for testing. Lancets are being increasingly used by patients affected by cardiovascular and endocrine-related complications. These devices are being used for cholesterol and glucose tests, heelstick screening tests or phenylketonuria (PKU) tests in newborns, as well as for severely burned or scarred emergency patients, extremely obese patients and thrombotic-tendency patients.

Safety Lancets Market contains market size and forecasts of Safety Lancets in global, including the following market information:

• Global Safety Lancets Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Safety Lancets Market Sales, 2017-2022, 2023-2028, (M Units)
• Global top five Safety Lancets companies in 2021 (%)

The global Safety Lancets market was valued at 535.1 million in 2021 and is projected to reach US$ 942.3 million by 2028, at a CAGR of 8.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Needle Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Safety Lancets include Roche, BD, Bayer, Lifescan, B. Braun, Terumo, Nipro, Sarstedt and ARKRAY, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Safety Lancets manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Safety Lancets Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Safety Lancets Market Segment Percentages, by Type, 2021 (%)

• Needle
• Blade

Global Safety Lancets Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Safety Lancets Market Segment Percentages, by Application, 2021 (%)

• Hospital and Clinics
• Diagnostic Centers
• Home Diagnostics
• Others

Global Safety Lancets Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Safety Lancets Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Safety Lancets revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Safety Lancets revenues share in global market, 2021 (%)
• Key companies Safety Lancets sales in global market, 2017-2022 (Estimated), (M Units)
• Key companies Safety Lancets sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Roche
• BD
• Bayer
• Lifescan
• B. Braun
• Terumo
• Nipro
• Sarstedt
• ARKRAY
• Smiths Medical
• Owen Mumford
• HemoCue
• Greiner Bio One